Last updated 2026-07-27
- Went public on NASDAQ Capital Market (IMCC), Mar 2021
- Acquired Blackaxe Technologies, Mar 2026
- Acquired Oranim Pharm, Mar 2022
Total raised
$69.5M
Last: Convertible Debt 2026-07
Stage
Public
Founded
2008
Headcount
44
HQ
Glil Yam, Israel
Sector
Health Tech & Life Sciences
About
IM Cannabis Corp. is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany. The company operates through an integrated model that includes import, distribution, retail pharmacies, and digital platforms. It leverages a data-driven approach and a globally sourced product supply chain. The company's ecosystem in Israel operates through subsidiaries that import and distribute cannabis, and it also runs medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs. In Germany, IM Cannabis operates through Adjupharm GmbH, distributing cannabis to pharmacies for medical patients.
Funding history · 13 rounds · $69.5M total
2026-04
PIPE
$550K
2025-08
PIPE
$4.1M
★ Pure Equity Ltd.
2025-06
Debt Financing
$1.0M
★ L.I.A. PURE CAPITAL
2024-10
PIPE
$2.1M
2023-09
Debt Financing
$950K
2022-12
PIPE
$6.7M
2022-12
PIPE
$2.0M
2022-09
PIPE
$3.0M
2022-07
PIPE
$5.0M
2021-04
PIPE
$35.0M
2021-02
Follow-on PO
Undisclosed
2019-09
Reverse Merger
Undisclosed
2018-04
Undisclosed Round
$9.1M
★ GlenRock Group
Q&A
- What is IM Cannabis's primary business focus?
- IM Cannabis is an international cannabis company focused on providing premium cannabis products to medical patients in Israel and Germany.
- When did IM Cannabis become a public company on NASDAQ?
- IM Cannabis became public on NASDAQ in March 2021.
- What was the most recent funding round for IM Cannabis?
- In July 2026, IM Cannabis completed a Convertible Debt round, raising US$225,000.
- What was IM Cannabis's total amount raised in funding?
- IM Cannabis has raised a total of US$7,271,660.4 in funding.
- What is the employee count for IM Cannabis?
- IM Cannabis has 11-50 employees.
- What was a significant acquisition made by IM Cannabis in 2026?
- In March 2026, IM Cannabis acquired Blackaxe Technologies.
- What strategic move did IM Cannabis announce in June 2026 regarding its European operations?
- In June 2026, IM Cannabis Corp. entered into a Letter of Intent to sell its European activities, expecting to significantly reduce debt by CAD$10.5 million.
- What financial results did IM Cannabis report for the first quarter of 2026?
- IM Cannabis Corp. announced its first quarter 2026 financial results in May 2026.
- What was a key financial announcement from IM Cannabis in January 2026?
- In January 2026, IM Cannabis raised US$2,171,660.40 in Note Purchase Agreements.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
medical-cannabis
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | imcannabis.com/ |
|---|---|
| linkedin.com/company/imc-israel |
Identifiers & details
| Legal name | IM Cannabis Corp. |
|---|---|
| Founded | 2008 |
| Employees (exact) | 44 |
| Market cap | $1.8M |
| Status reason | Public on CSE on Oct 2019;Public on NASDAQ on Mar 2021; |
Acquisitions & public offerings
| Acquired | Date | Amount |
|---|---|---|
| Blackaxe Technologies | 2026-03 | |
| Oranim Pharm | 2022-03 | |
| MYM Nutraceuticals | 2021-04 | |
| Trichome Financial | 2021-03 |
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| IPO | 2021-03 | NASDAQ Capital Market | IMCC |